{"id":226233,"date":"2025-12-10T21:24:08","date_gmt":"2025-12-10T21:24:08","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/226233\/"},"modified":"2025-12-10T21:24:08","modified_gmt":"2025-12-10T21:24:08","slug":"promotional-labeling-and-advertising-considerations-for-prescription-b-fda-gov","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/226233\/","title":{"rendered":"Promotional Labeling and Advertising Considerations for Prescription B – fda.gov"},"content":{"rendered":"
    \n
  1. Promotional Labeling and Advertising Considerations for Prescription B<\/a>  fda.gov<\/li>\n
  2. FDA finalizes guidance on promotional materials for biologics and biosimilars<\/a>  Fierce Pharma<\/li>\n
  3. BRIEF\u2014FDA final guidance on promotional labeling and advertising for biosimilars<\/a>  The Pharma Letter<\/li>\n
  4. Is FDA Streamlining Regulations in the Biosimilar Space?<\/a>  Pharmaceutical Executive<\/li>\n
  5. Parexel Exec On How CROs Should Prepare For Biosimilar Pathway, AI-Led Changes<\/a>  Citeline News & Insights<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Promotional Labeling and Advertising Considerations for Prescription B  fda.gov FDA finalizes guidance on promotional materials for biologics and biosimilars  Fierce…\n","protected":false},"author":2,"featured_media":1279,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[274],"tags":[18,135,19,17,462],"class_list":{"0":"post-226233","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-eire","9":"tag-health","10":"tag-ie","11":"tag-ireland","12":"tag-medication"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115697383127379076","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/226233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=226233"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/226233\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/1279"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=226233"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=226233"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=226233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}